0.94
-0.25(-21.01%)
Currency In USD
| Previous Close | 1.19 |
| Open | 1.19 |
| Day High | 1.22 |
| Day Low | 0.9 |
| 52-Week High | 231.15 |
| 52-Week Low | 0.9 |
| Volume | 5.5M |
| Average Volume | 3.87M |
| Market Cap | 954,933 |
| PE | 0 |
| EPS | -804.49 |
| Moving Average 50 Days | 17.47 |
| Moving Average 200 Days | 61.06 |
| Change | -0.25 |
If you invested $1000 in Aclarion, Inc. (ACON) since IPO date, it would be worth $0.06 as of March 12, 2025 at a share price of $0.94. Whereas If you bought $1000 worth of Aclarion, Inc. (ACON) shares 2 years ago, it would be worth $0.26 as of March 12, 2025 at a share price of $0.94.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Aclarion Announces Expansion Plans with RadNet Affiliates in New York and New Jersey
GlobeNewswire Inc.
Mar 06, 2025 2:35 PM GMT
Lenox Hill Radiology (LHR) in New York and New Jersey Imaging Network (NJIN) to add Nociscan across multiple sitesBROOMFIELD, Colo., March 06, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcar
Aclarion Announces First Commercial Agreement with Scripps Health
GlobeNewswire Inc.
Mar 03, 2025 11:00 AM GMT
Agreement expands access to Nociscan technology for leading spine physicians and more than 3.2M people in the greater San Diego Metro area Nociscan leverages MR Spectroscopy (MRS) and Augmented Intelligence (AI) to Identify Sources of Chronic Low Bac
Aclarion, Inc. Announces Adjournment of Special Meeting of Stockholders
GlobeNewswire Inc.
Feb 28, 2025 9:01 PM GMT
Meeting adjourned to Wednesday, March 5, 2025 at 9:30 a.m. Mountain TimeBROOMFIELD, Colo., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc. ("Aclarion" or the "Company") (NASDAQ: ACON) (NASDAQ: ACONW), a healthcare technology company that leverages